Targeting RNA with Therapeutics - Dr. Matthew Disney
from Talking Biotech with Dr. Kevin Folta
Summary In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Talking Biotech with Dr. Kevin Folta?
This episode is 41 minutes long.
When was this Talking Biotech with Dr. Kevin Folta episode published?
This episode was published on October 5, 2025.
Can I download this Talking Biotech with Dr. Kevin Folta episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.